nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2D6—Vinorelbine—ovarian cancer	0.0896	0.213	CbGbCtD
Proguanil—CYP3A4—Topotecan—ovarian cancer	0.0809	0.192	CbGbCtD
Proguanil—CYP2C9—Paclitaxel—ovarian cancer	0.0688	0.164	CbGbCtD
Proguanil—CYP3A4—Vinorelbine—ovarian cancer	0.057	0.135	CbGbCtD
Proguanil—CYP3A4—Paclitaxel—ovarian cancer	0.04	0.0951	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—ovarian cancer	0.0339	0.0806	CbGbCtD
Proguanil—CYP3A4—Docetaxel—ovarian cancer	0.0289	0.0688	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—ovarian cancer	0.0216	0.0513	CbGbCtD
Proguanil—Pancytopenia—Altretamine—ovarian cancer	0.0136	0.0417	CcSEcCtD
Proguanil—Anorexia—Altretamine—ovarian cancer	0.00779	0.0238	CcSEcCtD
Proguanil—Decreased appetite—Altretamine—ovarian cancer	0.0071	0.0217	CcSEcCtD
Proguanil—Vomiting—Altretamine—ovarian cancer	0.0052	0.0159	CcSEcCtD
Proguanil—Nausea—Altretamine—ovarian cancer	0.00485	0.0148	CcSEcCtD
Proguanil—Pancytopenia—Chlorambucil—ovarian cancer	0.00485	0.0148	CcSEcCtD
Proguanil—Body temperature increased—Carboplatin—ovarian cancer	0.00446	0.0136	CcSEcCtD
Proguanil—Stomatitis—Chlorambucil—ovarian cancer	0.00444	0.0136	CcSEcCtD
Proguanil—Pancytopenia—Topotecan—ovarian cancer	0.00432	0.0132	CcSEcCtD
Proguanil—Pancytopenia—Melphalan—ovarian cancer	0.00423	0.0129	CcSEcCtD
Proguanil—Hallucination—Chlorambucil—ovarian cancer	0.00407	0.0124	CcSEcCtD
Proguanil—Stomatitis—Topotecan—ovarian cancer	0.00395	0.0121	CcSEcCtD
Proguanil—Stomatitis—Melphalan—ovarian cancer	0.00387	0.0118	CcSEcCtD
Proguanil—Hepatobiliary disease—Topotecan—ovarian cancer	0.00383	0.0117	CcSEcCtD
Proguanil—Hepatobiliary disease—Melphalan—ovarian cancer	0.00375	0.0115	CcSEcCtD
Proguanil—Pancytopenia—Vinorelbine—ovarian cancer	0.00369	0.0113	CcSEcCtD
Proguanil—DHFR—myometrium—ovarian cancer	0.00359	0.098	CbGeAlD
Proguanil—DHFR—embryo—ovarian cancer	0.00345	0.0942	CbGeAlD
Proguanil—Stomatitis—Vinorelbine—ovarian cancer	0.00338	0.0103	CcSEcCtD
Proguanil—Immune system disorder—Topotecan—ovarian cancer	0.00329	0.01	CcSEcCtD
Proguanil—Mediastinal disorder—Topotecan—ovarian cancer	0.00328	0.01	CcSEcCtD
Proguanil—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.00328	0.01	CcSEcCtD
Proguanil—Immune system disorder—Melphalan—ovarian cancer	0.00322	0.00983	CcSEcCtD
Proguanil—Mediastinal disorder—Melphalan—ovarian cancer	0.00321	0.0098	CcSEcCtD
Proguanil—Malnutrition—Topotecan—ovarian cancer	0.00317	0.00967	CcSEcCtD
Proguanil—Immune system disorder—Vinorelbine—ovarian cancer	0.00281	0.00858	CcSEcCtD
Proguanil—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00281	0.00857	CcSEcCtD
Proguanil—DHFR—uterine cervix—ovarian cancer	0.00279	0.0762	CbGeAlD
Proguanil—Anorexia—Chlorambucil—ovarian cancer	0.00277	0.00845	CcSEcCtD
Proguanil—Cough—Topotecan—ovarian cancer	0.00276	0.00844	CcSEcCtD
Proguanil—Erythema—Vinorelbine—ovarian cancer	0.00271	0.00827	CcSEcCtD
Proguanil—Malnutrition—Vinorelbine—ovarian cancer	0.00271	0.00827	CcSEcCtD
Proguanil—Cough—Melphalan—ovarian cancer	0.00271	0.00826	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00268	0.00818	CcSEcCtD
Proguanil—DHFR—decidua—ovarian cancer	0.00266	0.0726	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00262	0.00801	CcSEcCtD
Proguanil—Nervous system disorder—Topotecan—ovarian cancer	0.00254	0.00774	CcSEcCtD
Proguanil—DHFR—endometrium—ovarian cancer	0.00253	0.0689	CbGeAlD
Proguanil—Decreased appetite—Chlorambucil—ovarian cancer	0.00252	0.00771	CcSEcCtD
Proguanil—Skin disorder—Topotecan—ovarian cancer	0.00251	0.00767	CcSEcCtD
Proguanil—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00251	0.00765	CcSEcCtD
Proguanil—Pancytopenia—Paclitaxel—ovarian cancer	0.00248	0.00758	CcSEcCtD
Proguanil—Anorexia—Topotecan—ovarian cancer	0.00246	0.00752	CcSEcCtD
Proguanil—Skin disorder—Melphalan—ovarian cancer	0.00246	0.00751	CcSEcCtD
Proguanil—Anorexia—Melphalan—ovarian cancer	0.00241	0.00737	CcSEcCtD
Proguanil—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00238	0.00725	CcSEcCtD
Proguanil—Cough—Vinorelbine—ovarian cancer	0.00236	0.00722	CcSEcCtD
Proguanil—DHFR—gonad—ovarian cancer	0.00234	0.064	CbGeAlD
Proguanil—DHFR—uterus—ovarian cancer	0.00233	0.0635	CbGeAlD
Proguanil—Body temperature increased—Chlorambucil—ovarian cancer	0.0023	0.00701	CcSEcCtD
Proguanil—Abdominal pain—Chlorambucil—ovarian cancer	0.0023	0.00701	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00229	0.007	CcSEcCtD
Proguanil—Stomatitis—Paclitaxel—ovarian cancer	0.00227	0.00694	CcSEcCtD
Proguanil—Decreased appetite—Topotecan—ovarian cancer	0.00225	0.00686	CcSEcCtD
Proguanil—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00223	0.00681	CcSEcCtD
Proguanil—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00221	0.00673	CcSEcCtD
Proguanil—Decreased appetite—Melphalan—ovarian cancer	0.0022	0.00672	CcSEcCtD
Proguanil—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00219	0.00667	CcSEcCtD
Proguanil—Nervous system disorder—Vinorelbine—ovarian cancer	0.00217	0.00662	CcSEcCtD
Proguanil—Skin disorder—Vinorelbine—ovarian cancer	0.00215	0.00656	CcSEcCtD
Proguanil—Gastrointestinal pain—Topotecan—ovarian cancer	0.00211	0.00645	CcSEcCtD
Proguanil—Anorexia—Vinorelbine—ovarian cancer	0.00211	0.00644	CcSEcCtD
Proguanil—Pancytopenia—Docetaxel—ovarian cancer	0.00211	0.00643	CcSEcCtD
Proguanil—DHFR—female reproductive system—ovarian cancer	0.00209	0.0571	CbGeAlD
Proguanil—Body temperature increased—Topotecan—ovarian cancer	0.00204	0.00624	CcSEcCtD
Proguanil—Abdominal pain—Topotecan—ovarian cancer	0.00204	0.00624	CcSEcCtD
Proguanil—Diarrhoea—Chlorambucil—ovarian cancer	0.00199	0.00607	CcSEcCtD
Proguanil—DHFR—bone marrow—ovarian cancer	0.00198	0.0539	CbGeAlD
Proguanil—Stomatitis—Docetaxel—ovarian cancer	0.00193	0.00588	CcSEcCtD
Proguanil—Decreased appetite—Vinorelbine—ovarian cancer	0.00192	0.00587	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00191	0.00583	CcSEcCtD
Proguanil—DHFR—female gonad—ovarian cancer	0.0019	0.052	CbGeAlD
Proguanil—DHFR—vagina—ovarian cancer	0.00189	0.0517	CbGeAlD
Proguanil—Immune system disorder—Paclitaxel—ovarian cancer	0.00189	0.00577	CcSEcCtD
Proguanil—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00189	0.00576	CcSEcCtD
Proguanil—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00187	0.00571	CcSEcCtD
Proguanil—Vomiting—Chlorambucil—ovarian cancer	0.00185	0.00564	CcSEcCtD
Proguanil—Mental disorder—Paclitaxel—ovarian cancer	0.00183	0.0056	CcSEcCtD
Proguanil—Malnutrition—Paclitaxel—ovarian cancer	0.00182	0.00556	CcSEcCtD
Proguanil—Erythema—Paclitaxel—ovarian cancer	0.00182	0.00556	CcSEcCtD
Proguanil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00181	0.00552	CcSEcCtD
Proguanil—Diarrhoea—Topotecan—ovarian cancer	0.00177	0.0054	CcSEcCtD
Proguanil—Abdominal pain—Vinorelbine—ovarian cancer	0.00175	0.00534	CcSEcCtD
Proguanil—Body temperature increased—Vinorelbine—ovarian cancer	0.00175	0.00534	CcSEcCtD
Proguanil—Diarrhoea—Melphalan—ovarian cancer	0.00173	0.00529	CcSEcCtD
Proguanil—Nausea—Chlorambucil—ovarian cancer	0.00173	0.00527	CcSEcCtD
Proguanil—DHFR—testis—ovarian cancer	0.00169	0.0461	CbGeAlD
Proguanil—Vomiting—Topotecan—ovarian cancer	0.00164	0.00502	CcSEcCtD
Proguanil—Rash—Topotecan—ovarian cancer	0.00163	0.00498	CcSEcCtD
Proguanil—Dermatitis—Topotecan—ovarian cancer	0.00163	0.00497	CcSEcCtD
Proguanil—Headache—Topotecan—ovarian cancer	0.00162	0.00494	CcSEcCtD
Proguanil—Vomiting—Melphalan—ovarian cancer	0.00161	0.00491	CcSEcCtD
Proguanil—Immune system disorder—Docetaxel—ovarian cancer	0.0016	0.00489	CcSEcCtD
Proguanil—Mediastinal disorder—Docetaxel—ovarian cancer	0.0016	0.00488	CcSEcCtD
Proguanil—Rash—Melphalan—ovarian cancer	0.0016	0.00487	CcSEcCtD
Proguanil—Dermatitis—Melphalan—ovarian cancer	0.00159	0.00487	CcSEcCtD
Proguanil—Cough—Paclitaxel—ovarian cancer	0.00159	0.00486	CcSEcCtD
Proguanil—Mental disorder—Docetaxel—ovarian cancer	0.00156	0.00475	CcSEcCtD
Proguanil—Erythema—Docetaxel—ovarian cancer	0.00155	0.00472	CcSEcCtD
Proguanil—Malnutrition—Docetaxel—ovarian cancer	0.00155	0.00472	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00154	0.00471	CcSEcCtD
Proguanil—Nausea—Topotecan—ovarian cancer	0.00154	0.00469	CcSEcCtD
Proguanil—Diarrhoea—Vinorelbine—ovarian cancer	0.00151	0.00462	CcSEcCtD
Proguanil—Nausea—Melphalan—ovarian cancer	0.0015	0.00459	CcSEcCtD
Proguanil—Nervous system disorder—Paclitaxel—ovarian cancer	0.00146	0.00445	CcSEcCtD
Proguanil—Skin disorder—Paclitaxel—ovarian cancer	0.00145	0.00441	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—ovarian cancer	0.00142	0.00434	CcSEcCtD
Proguanil—Anorexia—Paclitaxel—ovarian cancer	0.00142	0.00433	CcSEcCtD
Proguanil—Vomiting—Vinorelbine—ovarian cancer	0.00141	0.00429	CcSEcCtD
Proguanil—Rash—Vinorelbine—ovarian cancer	0.00139	0.00426	CcSEcCtD
Proguanil—Dermatitis—Vinorelbine—ovarian cancer	0.00139	0.00425	CcSEcCtD
Proguanil—Headache—Vinorelbine—ovarian cancer	0.00139	0.00423	CcSEcCtD
Proguanil—Cough—Docetaxel—ovarian cancer	0.00135	0.00412	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—ovarian cancer	0.00131	0.00401	CcSEcCtD
Proguanil—Nausea—Vinorelbine—ovarian cancer	0.00131	0.00401	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00131	0.00399	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—ovarian cancer	0.0013	0.00397	CcSEcCtD
Proguanil—Decreased appetite—Paclitaxel—ovarian cancer	0.00129	0.00395	CcSEcCtD
Proguanil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00128	0.00392	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00126	0.00385	CcSEcCtD
Proguanil—Nervous system disorder—Docetaxel—ovarian cancer	0.00124	0.00378	CcSEcCtD
Proguanil—Skin disorder—Docetaxel—ovarian cancer	0.00122	0.00374	CcSEcCtD
Proguanil—DHFR—lymph node—ovarian cancer	0.00122	0.0334	CbGeAlD
Proguanil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00122	0.00371	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—ovarian cancer	0.0012	0.00367	CcSEcCtD
Proguanil—Anorexia—Docetaxel—ovarian cancer	0.0012	0.00367	CcSEcCtD
Proguanil—Body temperature increased—Paclitaxel—ovarian cancer	0.00118	0.00359	CcSEcCtD
Proguanil—Abdominal pain—Paclitaxel—ovarian cancer	0.00118	0.00359	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00117	0.00356	CcSEcCtD
Proguanil—Decreased appetite—Docetaxel—ovarian cancer	0.0011	0.00335	CcSEcCtD
Proguanil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00109	0.00332	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—ovarian cancer	0.00108	0.0033	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—ovarian cancer	0.00108	0.00329	CcSEcCtD
Proguanil—CYP2C19—vagina—ovarian cancer	0.00108	0.0294	CbGeAlD
Proguanil—Mental disorder—Epirubicin—ovarian cancer	0.00105	0.0032	CcSEcCtD
Proguanil—Erythema—Epirubicin—ovarian cancer	0.00104	0.00318	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—ovarian cancer	0.00104	0.00318	CcSEcCtD
Proguanil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00103	0.00315	CcSEcCtD
Proguanil—Diarrhoea—Paclitaxel—ovarian cancer	0.00102	0.00311	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—ovarian cancer	0.001	0.00305	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000998	0.00305	CcSEcCtD
Proguanil—Abdominal pain—Docetaxel—ovarian cancer	0.000997	0.00304	CcSEcCtD
Proguanil—Body temperature increased—Docetaxel—ovarian cancer	0.000997	0.00304	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—ovarian cancer	0.00097	0.00296	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—ovarian cancer	0.000964	0.00294	CcSEcCtD
Proguanil—Erythema—Doxorubicin—ovarian cancer	0.000964	0.00294	CcSEcCtD
Proguanil—Vomiting—Paclitaxel—ovarian cancer	0.000946	0.00289	CcSEcCtD
Proguanil—Rash—Paclitaxel—ovarian cancer	0.000938	0.00286	CcSEcCtD
Proguanil—Dermatitis—Paclitaxel—ovarian cancer	0.000937	0.00286	CcSEcCtD
Proguanil—Headache—Paclitaxel—ovarian cancer	0.000932	0.00285	CcSEcCtD
Proguanil—CYP2C9—female reproductive system—ovarian cancer	0.000923	0.0252	CbGeAlD
Proguanil—Cough—Epirubicin—ovarian cancer	0.000909	0.00278	CcSEcCtD
Proguanil—Nausea—Paclitaxel—ovarian cancer	0.000884	0.0027	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000881	0.00269	CcSEcCtD
Proguanil—CYP2E1—female reproductive system—ovarian cancer	0.000875	0.0239	CbGeAlD
Proguanil—Diarrhoea—Docetaxel—ovarian cancer	0.000863	0.00263	CcSEcCtD
Proguanil—Cough—Doxorubicin—ovarian cancer	0.000841	0.00257	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—ovarian cancer	0.000834	0.00255	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—ovarian cancer	0.000826	0.00252	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000815	0.00249	CcSEcCtD
Proguanil—Anorexia—Epirubicin—ovarian cancer	0.000811	0.00248	CcSEcCtD
Proguanil—Vomiting—Docetaxel—ovarian cancer	0.000802	0.00245	CcSEcCtD
Proguanil—Rash—Docetaxel—ovarian cancer	0.000795	0.00243	CcSEcCtD
Proguanil—Dermatitis—Docetaxel—ovarian cancer	0.000794	0.00243	CcSEcCtD
Proguanil—Headache—Docetaxel—ovarian cancer	0.00079	0.00241	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000772	0.00236	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—ovarian cancer	0.000764	0.00233	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—ovarian cancer	0.00075	0.00229	CcSEcCtD
Proguanil—Nausea—Docetaxel—ovarian cancer	0.000749	0.00229	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—ovarian cancer	0.000739	0.00226	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000734	0.00224	CcSEcCtD
Proguanil—CYP2E1—testis—ovarian cancer	0.000706	0.0193	CbGeAlD
Proguanil—CYP3A4—female reproductive system—ovarian cancer	0.000704	0.0192	CbGeAlD
Proguanil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000696	0.00212	CcSEcCtD
Proguanil—CYP2D6—female reproductive system—ovarian cancer	0.000693	0.0189	CbGeAlD
Proguanil—Decreased appetite—Doxorubicin—ovarian cancer	0.000684	0.00209	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000679	0.00207	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—ovarian cancer	0.000672	0.00205	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—ovarian cancer	0.000672	0.00205	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000644	0.00196	CcSEcCtD
Proguanil—CYP2D6—female gonad—ovarian cancer	0.00063	0.0172	CbGeAlD
Proguanil—Abdominal pain—Doxorubicin—ovarian cancer	0.000622	0.0019	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—ovarian cancer	0.000622	0.0019	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—ovarian cancer	0.000582	0.00178	CcSEcCtD
Proguanil—CYP2D6—testis—ovarian cancer	0.000559	0.0153	CbGeAlD
Proguanil—Vomiting—Epirubicin—ovarian cancer	0.000541	0.00165	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—ovarian cancer	0.000538	0.00164	CcSEcCtD
Proguanil—Rash—Epirubicin—ovarian cancer	0.000536	0.00164	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—ovarian cancer	0.000536	0.00164	CcSEcCtD
Proguanil—Headache—Epirubicin—ovarian cancer	0.000533	0.00163	CcSEcCtD
Proguanil—Nausea—Epirubicin—ovarian cancer	0.000505	0.00154	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—ovarian cancer	0.0005	0.00153	CcSEcCtD
Proguanil—Rash—Doxorubicin—ovarian cancer	0.000496	0.00151	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—ovarian cancer	0.000496	0.00151	CcSEcCtD
Proguanil—Headache—Doxorubicin—ovarian cancer	0.000493	0.00151	CcSEcCtD
Proguanil—Nausea—Doxorubicin—ovarian cancer	0.000467	0.00143	CcSEcCtD
Proguanil—DHFR—G1/S Transition—MYC—ovarian cancer	0.000462	0.00215	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000454	0.00211	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000411	0.00191	CbGpPWpGaD
Proguanil—DHFR—Disease—PPP1CC—ovarian cancer	0.000402	0.00187	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000397	0.00185	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CHEK2—ovarian cancer	0.000392	0.00182	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.000389	0.00181	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000387	0.0018	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYTB—ovarian cancer	0.000385	0.00179	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.00038	0.00177	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000378	0.00176	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000373	0.00173	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCND2—ovarian cancer	0.000367	0.00171	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BRCA1—ovarian cancer	0.000367	0.00171	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.00036	0.00167	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000353	0.00164	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.000351	0.00163	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—PPP2R1A—ovarian cancer	0.000346	0.00161	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000346	0.00161	CbGpPWpGaD
Proguanil—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.00034	0.00158	CbGpPWpGaD
Proguanil—DHFR—Metabolism—BRIP1—ovarian cancer	0.000337	0.00157	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPP1CC—ovarian cancer	0.000337	0.00157	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BRCA2—ovarian cancer	0.000332	0.00154	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCNE1—ovarian cancer	0.000322	0.0015	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—BIRC5—ovarian cancer	0.000318	0.00148	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TYMS—ovarian cancer	0.000316	0.00147	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000306	0.00142	CbGpPWpGaD
Proguanil—DHFR—Disease—HDAC6—ovarian cancer	0.000305	0.00142	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BIRC5—ovarian cancer	0.000284	0.00132	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TERT—ovarian cancer	0.000275	0.00128	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000271	0.00126	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000267	0.00124	CbGpPWpGaD
Proguanil—DHFR—Disease—XIAP—ovarian cancer	0.000264	0.00123	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000258	0.0012	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000258	0.0012	CbGpPWpGaD
Proguanil—DHFR—Disease—SMARCA4—ovarian cancer	0.000258	0.0012	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000253	0.00118	CbGpPWpGaD
Proguanil—DHFR—Disease—EREG—ovarian cancer	0.000251	0.00117	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000249	0.00116	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000247	0.00115	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000245	0.00114	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000243	0.00113	CbGpPWpGaD
Proguanil—DHFR—Metabolism—YAP1—ovarian cancer	0.000226	0.00105	CbGpPWpGaD
Proguanil—DHFR—Disease—FASN—ovarian cancer	0.00022	0.00102	CbGpPWpGaD
Proguanil—DHFR—Disease—PARP1—ovarian cancer	0.000219	0.00102	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000215	0.001	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NME2—ovarian cancer	0.000214	0.000995	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000212	0.000988	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000211	0.000981	CbGpPWpGaD
Proguanil—DHFR—Disease—SLC2A1—ovarian cancer	0.000209	0.000972	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000209	0.000971	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000208	0.000967	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000198	0.00092	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000194	0.0009	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000193	0.0009	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000193	0.0009	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00019	0.000885	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	0.000186	0.000867	CbGpPWpGaD
Proguanil—DHFR—Metabolism—FASN—ovarian cancer	0.000184	0.000857	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000183	0.00085	CbGpPWpGaD
Proguanil—DHFR—Metabolism—SLC5A5—ovarian cancer	0.000181	0.000843	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCND1—ovarian cancer	0.000178	0.000827	CbGpPWpGaD
Proguanil—DHFR—Disease—PPP2R1A—ovarian cancer	0.000178	0.000826	CbGpPWpGaD
Proguanil—DHFR—Metabolism—SLC2A1—ovarian cancer	0.000175	0.000814	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP1B1—ovarian cancer	0.000168	0.00078	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN1B—ovarian cancer	0.000167	0.000775	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NME2—ovarian cancer	0.000165	0.000767	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000163	0.000757	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000163	0.000756	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00016	0.000747	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCND1—ovarian cancer	0.000159	0.00074	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000155	0.000723	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NME2—ovarian cancer	0.000152	0.000706	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NME2—ovarian cancer	0.00015	0.0007	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPP2R1A—ovarian cancer	0.000149	0.000692	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MAPK3—ovarian cancer	0.000147	0.000682	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MYC—ovarian cancer	0.000143	0.000664	CbGpPWpGaD
Proguanil—DHFR—Disease—TERT—ovarian cancer	0.000141	0.000656	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00014	0.000651	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MAPK1—ovarian cancer	0.00014	0.000649	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ABCB1—ovarian cancer	0.000138	0.000643	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYTB—ovarian cancer	0.000138	0.000641	CbGpPWpGaD
Proguanil—DHFR—Metabolism—TYMS—ovarian cancer	0.000136	0.000631	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MAPK3—ovarian cancer	0.000131	0.00061	CbGpPWpGaD
Proguanil—DHFR—Disease—CAV1—ovarian cancer	0.000131	0.000607	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NME2—ovarian cancer	0.000129	0.000598	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000128	0.000594	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MYC—ovarian cancer	0.000128	0.000593	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MAPK1—ovarian cancer	0.000125	0.00058	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6ST—ovarian cancer	0.000124	0.000576	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—BRIP1—ovarian cancer	0.00012	0.00056	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPP1CC—ovarian cancer	0.00012	0.00056	CbGpPWpGaD
Proguanil—DHFR—Disease—APC—ovarian cancer	0.000119	0.000553	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000114	0.000531	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CAV1—ovarian cancer	0.000109	0.000509	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000109	0.000507	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYTB—ovarian cancer	0.000106	0.000495	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—ovarian cancer	0.000105	0.000487	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CD—ovarian cancer	0.000105	0.000486	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000104	0.000484	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000104	0.000483	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CG—ovarian cancer	9.96e-05	0.000463	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NME2—ovarian cancer	9.92e-05	0.000461	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYTB—ovarian cancer	9.78e-05	0.000455	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYTB—ovarian cancer	9.69e-05	0.000451	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.47e-05	0.000441	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—BRIP1—ovarian cancer	9.29e-05	0.000432	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPP1CC—ovarian cancer	9.29e-05	0.000432	CbGpPWpGaD
Proguanil—DHFR—Disease—ERBB2—ovarian cancer	9.23e-05	0.000429	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CB—ovarian cancer	9.11e-05	0.000424	CbGpPWpGaD
Proguanil—DHFR—Disease—MTOR—ovarian cancer	9.11e-05	0.000424	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.89e-05	0.000413	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CD—ovarian cancer	8.75e-05	0.000407	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN1B—ovarian cancer	8.55e-05	0.000398	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—BRIP1—ovarian cancer	8.55e-05	0.000398	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPP1CC—ovarian cancer	8.55e-05	0.000398	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	8.47e-05	0.000394	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—BRIP1—ovarian cancer	8.47e-05	0.000394	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYTB—ovarian cancer	8.28e-05	0.000385	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.1e-05	0.000377	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—YAP1—ovarian cancer	8.08e-05	0.000376	CbGpPWpGaD
Proguanil—DHFR—Disease—CTNNB1—ovarian cancer	8.08e-05	0.000376	CbGpPWpGaD
Proguanil—DHFR—Disease—PTEN—ovarian cancer	7.87e-05	0.000366	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CB—ovarian cancer	7.63e-05	0.000355	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.24e-05	0.000337	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.24e-05	0.000337	CbGpPWpGaD
Proguanil—DHFR—Disease—STAT3—ovarian cancer	7.04e-05	0.000328	CbGpPWpGaD
Proguanil—DHFR—Disease—NRAS—ovarian cancer	7.02e-05	0.000327	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.77e-05	0.000315	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK3—ovarian cancer	6.73e-05	0.000313	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—ovarian cancer	6.59e-05	0.000307	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—FASN—ovarian cancer	6.59e-05	0.000306	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—ovarian cancer	6.54e-05	0.000304	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC5A5—ovarian cancer	6.48e-05	0.000301	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK1—ovarian cancer	6.4e-05	0.000298	CbGpPWpGaD
Proguanil—DHFR—Disease—EGFR—ovarian cancer	6.4e-05	0.000298	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYTB—ovarian cancer	6.39e-05	0.000297	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC2A1—ovarian cancer	6.26e-05	0.000291	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—YAP1—ovarian cancer	6.23e-05	0.00029	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.17e-05	0.000287	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.17e-05	0.000287	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—ovarian cancer	6.05e-05	0.000281	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1B1—ovarian cancer	6e-05	0.000279	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—YAP1—ovarian cancer	5.73e-05	0.000267	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—YAP1—ovarian cancer	5.68e-05	0.000264	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.62e-05	0.000262	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.59e-05	0.00026	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.59e-05	0.00026	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—ovarian cancer	5.55e-05	0.000258	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.42e-05	0.000252	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.32e-05	0.000247	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.28e-05	0.000245	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—ovarian cancer	5.14e-05	0.000239	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—FASN—ovarian cancer	5.08e-05	0.000236	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5e-05	0.000232	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.94e-05	0.00023	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.94e-05	0.00023	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—ovarian cancer	4.92e-05	0.000229	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—YAP1—ovarian cancer	4.86e-05	0.000226	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—ovarian cancer	4.85e-05	0.000226	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.83e-05	0.000225	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.81e-05	0.000224	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.73e-05	0.00022	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—FASN—ovarian cancer	4.67e-05	0.000217	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—ovarian cancer	4.65e-05	0.000216	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—FASN—ovarian cancer	4.63e-05	0.000215	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.63e-05	0.000215	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.6e-05	0.000214	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.56e-05	0.000212	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—ovarian cancer	4.54e-05	0.000211	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.44e-05	0.000207	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.4e-05	0.000205	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.31e-05	0.0002	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.26e-05	0.000198	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.23e-05	0.000197	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.22e-05	0.000196	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.1e-05	0.000191	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.08e-05	0.00019	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—FASN—ovarian cancer	3.96e-05	0.000184	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CAV1—ovarian cancer	3.91e-05	0.000182	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.89e-05	0.000181	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.81e-05	0.000177	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—ovarian cancer	3.8e-05	0.000177	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.77e-05	0.000176	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.76e-05	0.000175	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—YAP1—ovarian cancer	3.75e-05	0.000174	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—ovarian cancer	3.74e-05	0.000174	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.74e-05	0.000174	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.72e-05	0.000173	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.68e-05	0.000171	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.61e-05	0.000168	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.56e-05	0.000166	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.5e-05	0.000163	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.47e-05	0.000162	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—ovarian cancer	3.44e-05	0.00016	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—ovarian cancer	3.41e-05	0.000159	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.2e-05	0.000149	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.18e-05	0.000148	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.13e-05	0.000146	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—FASN—ovarian cancer	3.06e-05	0.000142	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CAV1—ovarian cancer	3.02e-05	0.00014	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.01e-05	0.00014	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.97e-05	0.000138	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—ovarian cancer	2.92e-05	0.000136	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.9e-05	0.000135	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.88e-05	0.000134	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.78e-05	0.000129	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CAV1—ovarian cancer	2.77e-05	0.000129	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CAV1—ovarian cancer	2.75e-05	0.000128	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.75e-05	0.000128	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.73e-05	0.000127	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.63e-05	0.000122	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.53e-05	0.000118	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.5e-05	0.000117	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.47e-05	0.000115	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.41e-05	0.000112	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—ovarian cancer	2.36e-05	0.00011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CAV1—ovarian cancer	2.35e-05	0.000109	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.29e-05	0.000107	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—ovarian cancer	2.25e-05	0.000105	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.24e-05	0.000104	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.22e-05	0.000103	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.2e-05	0.000102	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.14e-05	9.96e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.1e-05	9.79e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.94e-05	9.01e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.92e-05	8.93e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.88e-05	8.75e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—ovarian cancer	1.82e-05	8.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CAV1—ovarian cancer	1.81e-05	8.44e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—ovarian cancer	1.67e-05	7.78e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.66e-05	7.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—ovarian cancer	1.66e-05	7.71e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.65e-05	7.68e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.64e-05	7.63e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.45e-05	6.75e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—ovarian cancer	1.42e-05	6.59e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—ovarian cancer	1.36e-05	6.32e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.28e-05	5.97e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.27e-05	5.89e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.18e-05	5.49e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.17e-05	5.44e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—ovarian cancer	1.09e-05	5.09e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—ovarian cancer	1.05e-05	4.88e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1e-05	4.65e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—ovarian cancer	9.64e-06	4.48e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—ovarian cancer	9.56e-06	4.45e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—ovarian cancer	8.17e-06	3.8e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.72e-06	3.59e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—ovarian cancer	6.3e-06	2.93e-05	CbGpPWpGaD
